Bormioli Pharma innovation for better performing and more sustainable product

Bormioli Pharma innovation for better performing and more sustainable product

Bormioli Pharma has announced new research and innovation projects through a series of initiatives carried out with an Open Innovation approach, combining internal resources with Research Centres, Universities and start-ups, the company aims to develop better performing and more sustainable glass products.

In particular, the collaboration with Istituto dei Materiali per l' Elettronica ed il Magnetismo (IMEM-CNR), within a new research centre dedicated to glass, is now underway to allow, through the funding of a three-year PhD scholarship, the development of new external and internal coatings able to increase the performance of glass, both from a chemical and mechanical point of view.

Performance-wise, the company is also experimenting with an innovative treatment to make Type II (soda–lime–silica) glass bottles even more resistant, thus ensuring greater stability of the pharmaceutical formulations they will contain.

Bormioli Pharma has recently joined Glass Futures to develop an innovative, low CO2 emission approach to glass production.

The project, which will last ten years, will soon see the opening of a pilot furnace in the UK dedicated to the experimentation and application of these technologies.

"In a celebration year for glass, we are ready to confirm our role as innovators in the industry, with several concrete research and development initiatives," commented Andrea Lodetti, CEO of Bormioli Pharma. "This commitment is all the more important in a sector such as pharmaceuticals, where glass must not only contain, but also protect the therapeutic efficacy, and where the constant increase in production requires a serious rethinking of our responsibilities towards the environment."

Sustainability is a key pillar for Bormioli Pharma, which has committed to manufacturing 50% of its products using materials with low environmental impact by 2025.

The company will also publish its first Integrated Report based on ESG parameters by H1 2022.

www.bormiolipharma.com

Image: Bormioli Pharma are developing new external and internal coatings to increase the performance of glass.

Published: 
10/02/2022

Hot Topics